Liver Diseases  >>  emtricitabine/tenofovir disoproxil fumarate  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
emtricitabine/tenofovir disoproxil fumarate / Generic mfg.
NCT00737568 / 2008-001464-36: Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine

Completed
3b
280
US, Canada, Europe, RoW
TDF, Viread®, FTC/TDF, Truvada®, TDF Placebo, FTC/TDF Placebo
Gilead Sciences
Hepatitis B
11/11
02/15
NCT00117676 / 2004-005119-27: A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B

Completed
3
382
US, Canada, Europe, RoW
TDF, Viread®, ADV, Hepsera®, TDF placebo, ADV placebo, FTC/TDF, Truvada®
Gilead Sciences
Chronic Hepatitis B
04/07
01/16
NCT00116805 / 2004-005120-41: A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B

Completed
3
266
US, Canada, Europe, RoW
TDF, Viread®, ADV, Hepsera®, TDF placebo, ADV placebo, FTC/TDF, Truvada®
Gilead Sciences
Chronic Hepatitis B
05/07
01/16
HB01EMVIPEG, NCT00391638: Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients

Completed
2/3
56
Europe
TRUVADA (EMTRICITABINE + TENOFOVIR DF), PEGASYS 180μg (Interféron pégylé alpha -2a)
French National Agency for Research on AIDS and Viral Hepatitis, Gilead Sciences, Roche Pharma AG
Hepatitis B, HIV Infections
05/11
10/12

Download Options